| European Trial of Pirfenidone in BOS, A European Multi-center Study (NCT02262299) | Rigshospitalet, Denmark | 2015-05-01 |
| Study of Debio 1450 for Bacterial Skin Infections (NCT02426918) | Debiopharm International SA | 2015-05-01 |
| Study of Everolimus as Maintenance Therapy for Metastatic NEC With Pulmonary or Gastroenteropancreatic Origin (NCT02687958) | Gruppo Oncologico Italiano di Ricerca Clinica | 2015-05-01 |
| SUBLIVAC FIX Mite Mixture Dose Tolerability Study (NCT02345278) | HAL Allergy | 2015-05-01 |
| S-1/Oxaliplatin for High Risk Patients Who Underwent Gastrectomy (NCT02191566) | Kangbuk Samsung Hospital | 2015-05-01 |
| PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer (NCT02483884) | Lantheus Biosciences Ltd. | 2015-05-01 |
| HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Cancer (NCT02447263) | Fuda Cancer Hospital, Guangzhou | 2015-05-01 |
| Targeting the Hippo Transducer TAZ in Breast Cancer With Statins (NCT02416427) | Regina Elena Cancer Institute | 2015-05-01 |
| A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251 (NCT02449018) | Novartis Pharmaceuticals | 2015-04-30 |
| Phase Ib, Single-arm Study of AZD6094 (Volitinib) in Combination With Docetaxel, in Any Solid Cancer and Sequential Phase II, Single-arm Study of AZD6094 (Volitinib) in Combination With Docetaxel in Advanced Gastric Adenocarcinoma Patients With MET Amplification as a Second Line Treatment (NCT02447406) | Samsung Medical Center | 2015-04-30 |
| Safety and Efficacy of Andecaliximab in Participants With Moderately to Severely Active Crohn's Disease (NCT02405442) | Gilead Sciences | 2015-04-30 |
| A Study Evaluating the Efficacy and Tolerability of Veliparib in Combination With Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Adults With Stage III Non-Small Cell Lung Cancer (NSCLC) (NCT02412371) | AbbVie | 2015-04-30 |
| Transarterial Chemoembolization Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma (NCT02470533) | Erasmus Medical Center | 2015-04-30 |
| Trial of Afatinib in Pediatric Tumours (NCT02372006) | Boehringer Ingelheim | 2015-04-29 |
| A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer (NCT02407054) | Eli Lilly and Company | 2015-04-29 |
| Effect of Gefapixant (AF-219/MK-7264) on Cough Reflex Sensitivity (MK-7264-015) (NCT02397460) | Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2015-04-29 |
| An Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) Monotherapy in Subjects With Advanced or Metastatic Squamous Cell (Sq) Non-Small Cell Lung Cancer (NSCLC) Who Have Received at Least One Prior Systemic Regimen for the Treatment of Stage IIIb/IV SqNSCLC (NCT02409368) | Bristol-Myers Squibb | 2015-04-29 |
| Assessing PA-824 for Tuberculosis (the APT Trial) (NCT02256696) | Johns Hopkins University | 2015-04-29 |
| A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH (NCT02279524) | Galmed Research and Development, Ltd. | 2015-04-29 |
| Study to Compare the Safety and Efficacy of CMB305 With Atezolizumab to Atezolizumab Alone in Participants With Sarcoma (IMDZ-C232/V943A-002) (NCT02609984) | Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2015-04-29 |
| A Study to Look at Tapentadol Tablets in Children and Adolescents in Pain (NCT02151682) | Grünenthal GmbH | 2015-04-29 |
| Pembrolizumab in Treating Patients With Recurrent Glioblastoma (NCT02337686) | M.D. Anderson Cancer Center | 2015-04-28 |
| Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy (NCT02366871) | University of Colorado, Denver | 2015-04-28 |
| A Phase 2a Study to Assess Safety & Pharmacokinetics of Sustained Release Sodium Nitrite in Patients With Diabetic Pain (NCT02412852) | TheraVasc Inc. | 2015-04-28 |
| A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis (PsA) Who Have an Inadequate Response to Methotrexate (MTX) (NCT02349451) | AbbVie | 2015-04-28 |
| Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography (NCT02455453) | Washington University School of Medicine | 2015-04-28 |
| Phase II Safety and Tolerability Trial With Nab-Paclitaxel Plus Carboplatin Followed by Nab-Paclitaxel for First Line Treatment of NSCLC Subjects With ECOG PS 2 (NCT02289456) | Celgene | 2015-04-28 |
| Study of GSK2862277 in Subjects Undergoing Oesophagectomy Surgery (NCT02221037) | GlaxoSmithKline | 2015-04-28 |
| Pazopanib in Molecularly Selected Patients With Advanced NSCLC (NCT02193152) | Washington University School of Medicine | 2015-04-27 |
| High Dose Chemotherapy Using BeEAM for Autologous Transplant in Multiple Myeloma (NCT02416206) | Northside Hospital, Inc. | 2015-04-27 |
| Buparlisib in Patients With Relapsed and Refractory Chronic Lymphocytic Leukemia (NCT02340780) | Canadian Cancer Trials Group | 2015-04-27 |
| AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients (NCT02388295) | AstraZeneca | 2015-04-27 |
| Phase I/II Study of PDR001 in Patients With Advanced Malignancies (NCT02404441) | Novartis Pharmaceuticals | 2015-04-27 |
| Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall (LIPO-MYX Trial) (NCT03816475) | Maria Sklodowska-Curie National Research Institute of Oncology | 2015-04-24 |
| Study of Sirolimus Therapy for Segmental Overgrowth Caused by Somatic PI3K Activation (NCT02428296) | National Human Genome Research Institute (NHGRI) | 2015-04-23 |
| Use of Topical Subgingival Application of Simvastatin Gel in the Treatment of Peri-Implant Mucositis (NCT03400475) | Ahmed Mohamed Mahrous | 2015-04-23 |
| Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature (NCT02375620) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2015-04-23 |
| Two and Three Dimensional Contrast-enhanced Ultrasound for Screening of Renal Cell Carcinoma Recurrence Following Cryoablation (NCT02440334) | Thomas Jefferson University | 2015-04-23 |
| An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer (NCT02365597) | Janssen Research & Development, LLC | 2015-04-22 |
| Mocetinostat (MGCD0103) Plus Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Hodgkin Lymphoma (NCT02429375) | Memorial Sloan Kettering Cancer Center | 2015-04-22 |
| Gabapentin in Reducing the Need for Pain Medication in Patients With Bladder Cancer Undergoing Radical Cystectomy (NCT02355886) | University of Washington | 2015-04-22 |
| Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC) (NCT02301143) | Celgene | 2015-04-21 |
| Japanese Phase Ib/II Copanlisib in Relapsed, Indolent B-cell NHL (NCT02342665) | Bayer | 2015-04-21 |
| Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma (NCT02348216) | Kite, A Gilead Company | 2015-04-21 |
| Lirilumab and Azacitidine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia (NCT02399917) | M.D. Anderson Cancer Center | 2015-04-20 |
| A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain (NCT02308020) | Eli Lilly and Company | 2015-04-20 |
| Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer (NCT02200757) | ImmunityBio, Inc. | 2015-04-20 |
| miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome (NCT02418195) | University of Alabama at Birmingham | 2015-04-20 |
| Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal Adenocarcinoma (NCT02289898) | OncoMed Pharmaceuticals, Inc. | 2015-04-20 |
| A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome (NCT02293395) | Janssen Research & Development, LLC | 2015-04-20 |
| Vitamin B12, Neurodevelopment and Growth in Nepal (NCT02272842) | Centre For International Health | 2015-04-20 |
| A Study of BGB324 (Bemcentinib) in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer (NCT02424617) | BerGenBio ASA | 2015-04-19 |
| Pneumatic Reversible Portal Vein Diameter Modulation After Major Hepatectomy (NCT02390713) | Assistance Publique - Hôpitaux de Paris | 2015-04-18 |
| Thyroid Hormone to Induce Non-Insulin Mediated Glucose Disposal in People With Insulin Receptor Mutations (NCT02457897) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2015-04-17 |
| A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC) (NCT02291289) | Hoffmann-La Roche | 2015-04-17 |
| QUILT-3.002: N-803 in Patients With Relapse/Refractory iNHL in Conjunction With Rituximab (NCT02384954) | Altor BioScience | 2015-04-17 |
| Talazoparib Before Standard Therapy in Treating Patients With Invasive, BRCA-Mutated Breast Cancer (NCT02282345) | M.D. Anderson Cancer Center | 2015-04-16 |
| Phase I/II Study of Bosutinib in Combination With Inotuzumab Ozogamicin in CD22-positive PC Positive ALL and CML (NCT02311998) | M.D. Anderson Cancer Center | 2015-04-16 |
| AZD2014 and Weekly Paclitaxel in Squamous NSCLC (NCT02403895) | AstraZeneca | 2015-04-15 |
| Safety, Tolerability, Pharmacokinetic, and Efficacy Study of SPD489 in Preschool Children With Attention-deficit/Hyperactivity Disorder (NCT02402166) | Shire | 2015-04-15 |
| A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis With Hunner's Lesions (NCT02395042) | Allergan | 2015-04-15 |
| Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab (NCT02330562) | Celgene | 2015-04-15 |
| Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck (NCT02319044) | AstraZeneca | 2015-04-15 |
| Total Thyroidectomy With and Without Prophylactic Central Neck Lymph Node Dissection in People With Low-risk Papillary Thyroid Cancer (NCT02408887) | National Cancer Institute (NCI) | 2015-04-15 |
| A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer (NCT02439450) | Heat Biologics | 2015-04-15 |
| A Dose-Ranging Study Evaluating the Efficacy, Safety, and Tolerability of GSK2140944 in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae (NCT02294682) | GlaxoSmithKline | 2015-04-15 |
| Homologous Recombination Repair Status as a Biomarker of Response in Locally Recurrent/Metastatic Triple Negative Breast Cancer Patients Treated With Concurrent Cisplatin and Radiation Therapy (NCT02422498) | Memorial Sloan Kettering Cancer Center | 2015-04-14 |
| Open Label Extension Safety and Efficacy Study of TNX-102 SL Tablets in Military Related PTSD and Related Conditions (NCT02421679) | Tonix Pharmaceuticals, Inc. | 2015-04-14 |
| AADC Gene Therapy for Parkinson's Disease (NCT02418598) | Jichi Medical University | 2015-04-14 |
| An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies (NCT02431260) | Incyte Corporation | 2015-04-14 |
| Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Standard Therapies (NCT02369458) | Washington University School of Medicine | 2015-04-14 |
| Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies (NCT02419755) | St. Jude Children's Research Hospital | 2015-04-14 |
| Study of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Participants Who Have Completed Study HGT-HIT-094 (NCT02412787) | Shire | 2015-04-14 |
| Effects of Anticoagulant Preventive Injection in Patients With Blood Cancer (NCT02260414) | Centre Hospitalier Universitaire de Saint Etienne | 2015-04-14 |
| Elotuzumab and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma (NCT02420860) | M.D. Anderson Cancer Center | 2015-04-14 |
| Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD (NCT02255227) | Centre Hospitalier Universitaire de Saint Etienne | 2015-04-13 |
| Standard Care Alone or With Acupuncture for CIPN in Breast Cancer and Multiple Myeloma (NCT02275403) | The Christie NHS Foundation Trust | 2015-04-13 |
| Efficacy, Safety, and Pharmacokinetics Study of CJM112 in Hidradenitis Suppurativa Patients (NCT02421172) | Novartis Pharmaceuticals | 2015-04-13 |
| A Study to Evaluate Dose Responses of Efficacy and Safety of ASP0456 in Patient With Chronic Constipation (NCT02425722) | Astellas Pharma Inc | 2015-04-13 |
| Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders (NCT02324673) | INSYS Therapeutics Inc | 2015-04-13 |
| Clinical Evaluation of Polyherbal Coded Formulation Obesecure for Leptin Regulation and Obesity Management (NCT04443790) | Hafiz Muhammad Asif | 2015-04-10 |
| A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras Mutations (NCT02418000) | Spirita Oncology, LLC | 2015-04-10 |
| A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder (NCT02395978) | BioLite, Inc. | 2015-04-10 |
| 11C- and 18F-Choline PET/MR Imaging for Prostate Cancer (NCT02397408) | University of California, San Francisco | 2015-04-09 |
| Ocytocine and Cerebral Activation in Relation With Attachement (NCT02847143) | Centre Hospitalier Universitaire de Besancon | 2015-04-09 |
| An Extension Study to Determine Safety and Efficacy for Pediatric Patients With MPS Type IIIA Disease Who Participated in Study HGT-SAN-093. (NCT02350816) | Shire | 2015-04-08 |
| A Study of VLX1570 and Dexamethasone in Myeloma Patients (NCT02372240) | Vivolux AB | 2015-04-08 |
| Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery (NCT02315625) | National Cancer Institute (NCI) | 2015-04-08 |
| Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy (NCT02300545) | Washington University School of Medicine | 2015-04-08 |
| Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients (NCT02435849) | Novartis Pharmaceuticals | 2015-04-08 |
| Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to Methotrexate (NCT02393378) | Takeda | 2015-04-08 |
| Bortezomib Maintenance in High Risk DLBCL (NCT01965977) | Samsung Medical Center | 2015-04-08 |
| Nivolumab and Azacitidine With or Without Ipilimumab in Treating Patients With Refractory/Relapsed or Newly Diagnosed Acute Myeloid Leukemia (NCT02397720) | M.D. Anderson Cancer Center | 2015-04-07 |
| Effectiveness of BBT-I and Zopiclone for Chronic Insomnia (NCT03339583) | I.M. Sechenov First Moscow State Medical University | 2015-04-07 |
| Neurocognitive Driving Rehabilitation in Virtual Environments (NeuroDRIVE) as an Adjunctive Intervention for Traumatic Brain Injury (NCT02411227) | National Institutes of Health Clinical Center (CC) | 2015-04-07 |
| Single-arm Trial to Evaluate the Role of the Immune Response to Talimogene Laherparepvec in Unresected Melanoma (NCT02366195) | Amgen | 2015-04-07 |
| Atrasentan Spermatogenesis and Testicular Function (NCT02118714) | AbbVie | 2015-04-06 |
| AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites (NCT02417753) | National Cancer Institute (NCI) | 2015-04-03 |
| Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 Trial (NCT02541942) | Novo Nordisk A/S | 2015-04-03 |
| Simvastatin Around Immediate Implant (NCT04803500) | Ain Shams University | 2015-04-02 |